(Q43162409)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

chronic idiopathic myelofibrosis

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

W A Stewart

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R Pearce

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K E Kirkland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Bloor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K Thomson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Apperley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G McQuaker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D I Marks

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S McCann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Russell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G Cook

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P D Kottaridis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

British Society for Blood and Marrow Transplantation

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

15 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1587-1593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.14

18 January 2020

exact match

0 references

cites work

Biology and management of idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

The role of interferon-alpha in the treatment of idiopathic myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Choosing between stem cell therapy and drugs in myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

Myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Splenectomy and hemopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Stem cell transplantation for myelofibrosis: a report from two Canadian centers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Outcome of allogeneic stem cell transplantation in patients with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.14

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20154739%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 January 2020

1009258274

0 references

1 reference